{"url_path":"/sec/cntx/8-k/2026-06-26/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1842952/0001628280-26-045744-index.html","accession_number":"0001628280-26-045744","cik":"0001842952","ticker":"CNTX","issuer_name":"Context Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1842952/0001628280-26-045744-index.html","primary_entity_key":"0001842952","primary_entity_name":"Context Therapeutics Inc."},"word_count":351,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nAs of April 27, 2026, the record date for the Meeting, there were 91,879,177 shares of common stock issued and outstanding and entitled to vote on the proposals presented at the Meeting, of which 72,830,990, or approximately 79.27%, were present in person or represented by proxy, which constituted a quorum. The holders of shares of the Company’s common stock are entitled to one vote for each share held. Set forth below are the final voting results for each of the proposals submitted to a vote of the Company’s stockholders at the Meeting.\n\nProposal 1. Election of Directors\n\nThe Company’s stockholders elected the following seven director nominees to the Company’s Board of Directors, each to serve until the Company’s 2027 Annual Meeting of Stockholders or until his or her successor is elected and qualified or until his or her earlier death, resignation or removal.\n\nForWithholdBroker Non-Votes\n\nDr. Philip Kantoff63,340,79350,3109,439,887\n\nMartin Lehr63,369,77521,3289,439,887\n\nAndy Pasternak63,376,71214,3919,439,887\n\nDr. Karen Smith63,346,22544,8789,439,887\n\nJennifer Evans Stacey61,370,3912,020,7129,439,887\n\nDr. Luke Walker63,376,73214,3719,439,887\n\nLinda West63,339,28951,8149,439,887\n\nProposal 2. Ratification of Selection of Independent Registered Public Accounting Firm\n\nThe Company’s stockholders ratified the selection of CohnReznick LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2026. The voting on this proposal is set forth below:\n\nForAgainstAbstentionsBroker Non-Votes\n\nRatification of CohnReznick LLP72,762,15265,3953,443---\n\nProposal 3. Approval of Proposed Amendment to the Certificate\n\nThe Company’s stockholders approved an amendment to the Certificate to increase the number of authorized shares of the Company’s common stock from 200,000,000 to 300,000,000. The voting on this proposal is set forth below:\n\nForAgainstAbstentionsBroker Non-Votes\n\nAmendment to Certificate71,752,1651,050,86727,958---\n\nProposal 4. Approval of Meeting Adjournment\n\nThe Company’s stockholders approved one or more adjournments of the Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve Proposal 3 at the time of the Meeting. The voting on this proposal is set forth below:\n\nForAgainstAbstentionsBroker Non-Votes\n\nMeeting Adjournment71,827,930980,42522,635---\n\nAdjournment of the Meeting was not necessary or appropriate because there were sufficient votes in favor of Proposal 3."}